Get started
Author

Gaia Cairoli

Observed name: G. Cairoli
Institution: University of Pisa
OpenAlex ID: A5044577276
Blood Eosinophils Are Accurate Biomarkers for the Management of Eosinophilic Oesophagitis: Prospective, Multi‐Centre Study
2026 · Pierfrancesco Visaggi, Gaia Pellegatta, et al. · Alimentary Pharmacology & Therapeutics · 8
Efficacy of Dupilumab for Induction and Maintenance of Remission in Patients With Eosinophilic Gastritis, Enteritis, and Colitis With Concomitant Eosinophilic Esophagitis
2025 · Pierfrancesco Visaggi, Lorenzo Bini, et al. · Neurogastroenterology & Motility · 7
Acnmd26-358: La Grade a Esophagitis Does Not Differ From Nerd in Symptoms, Treatment Response, or Reflux Burden
2026 · Federico Testi, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease
Acnmd26-383: Higher Upper Esophageal Sphincter Pressure Differentiates Erosive From Non-erosive Reflux Disease: a High-resolution Manometry Study
2026 · Lorenzo Bini, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease
Acnmd26-390: Refractory Gerd Unmasked: Gut-brain Interaction Vs Anti-reflux Barrier Failure
2026 · Mattia Orazzini, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease
Acnmd26-346: Do We Really Need Two Different Esophageal Dgbi?
2026 · Mauro Mitilini, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease
Acnmd26-510: Manometric Integrity Predicts Reflux Burden: Correlation Between Milan Score, Aet and Mnbi
2026 · Gaia Cairoli, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease
Acnmd26-499: Efficacy of Budesonide Orodispersible Tablet Split Versus Single Dose for Maintenance of Remission in Eosinophilic Esophagitis: Total Daily Dose May Matter More Than the Administration Frequency
2026 · Pierfrancesco Visaggi, Gaia Cairoli, et al. · Digestive and Liver Disease
Sa1264: PERIPHERAL EOSINOPHILS ARE ACCURATE NON-INVASIVE BIOMARKERS FOR HISTOLOGICAL DISEASE ACTIVITY IN EOSINOPHILIC ESOPHAGITIS, BUT CORRELATION WITH CLINICAL SEVERITY IS INCONSISTENT: MULTICENTER PROSPECTIVE STUDY
2025 · Pierfrancesco Visaggi, Gaia Pellegatta, et al. · Gastroenterology
297: the Pisa Eoe Adaptation Questionnaire for Adaptive Behaviors Accurately Monitors Histological Disease Activity Trends Following Treatment in Patients With Eosinophilic Esophagitis : a Prospective, Longitudinal Study
2025 · Pierfrancesco Visaggi, Irene Solinas, et al. · Gastroenterology
Oc.01.5 Peripheral Eosinophils Are Accurate Non-invasive Biomarkers in the Diagnosis and Monitoring of Eosinophilic Esophagitis and Correlate With Endoscopic Disease Severity: a Multicenter Prospective Study Supporting That Eoe Is a Systemic Disease
2025 · P. Visaggi, G. Pellegatta, et al. · Digestive and Liver Disease
T.07.8 Dysphagia in Ineffective Esophageal Motility Is Not Explained by Evidence of Obstruction or Poorer Peristalsis at High-resolution Esophageal Manometry: Results From a Prospective Study
2025 · A. Giulia, P. Visaggi, et al. · Digestive and Liver Disease
Oc.01.4 Symptom Index and Symptom Association Probability Do Not Predict Objective Gastroesophageal Reflux Disease as Opposed to the Other Patient-independent Ph-impedance Metrics
2025 · M. Mitilini, P. Visaggi, et al. · Digestive and Liver Disease
T.01.8 Ranking of Ambulatory Reflux Monitoring Adjunctive Metrics for Predicting Treatment Response in Patients With Borderline Acid Exposure Time
2025 · F. Testi, P. Visaggi, et al. · Digestive and Liver Disease
Oc.13.4 Poliprotect Is Effective in Treating Both Acid and Nonacid Related Upper Gi Symptoms: Proof of Concept Study Comparing Patients With Chronic Autoimmune Atrophic Gastritis and Non-erosive Reflux Disease
2025 · G. Cairoli, P. Visaggi, et al. · Digestive and Liver Disease
Correspondence among capsule endoscopy findings and molecular signatures in atrophic enteropathies
2023 · N. Nandi, I. Lodola, et al. · Endoscopy
T.01.4 Role of Molecular Biomarkers in the Differential Diagnosis of Small Bowel Atrophy
2023 · N. Nandi, I. Lodola, et al. · Digestive and Liver Disease
Works count: 17
Citation count: 14
H-index: 2
I10-index:
Year
Topic
Type